Marie-Laure Ancelin researcher ORCID ID = 0000-0002-1149-4320
Ancelin, Marie-Laure, 1958-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 68995011 ( Personal )
Permalink: http://viaf.org/viaf/68995011
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| Anxiété généralisée du sujet âgé : rôle des facteurs bio-environnementaux et de la vulnérabilité génétique. |
|
| Aromatase (CYP19A1) gene variants, sex steroid levels, and late-life depression |
|
| The association between caffeine and cognitive decline: examining alternative causal hypotheses. |
|
| Association between DNA methylation of the KITLG gene and cortisol levels under stress: a replication study |
|
| Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression. |
|
| Biological and psychological predictors of posttraumatic stress disorder onset and chronicity. A one-year prospective study |
|
| Biological underpinnings of trauma and post-traumatic stress disorder: focusing on genetics and epigenetics. |
|
| Brain volumes in late life: gender, hormone treatment, and estrogen receptor variants. |
|
| Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence. |
|
| Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study. |
|
| Choline incorporation by Schistosoma mansoni: distribution of choline metabolites during development and after sexual differentiation |
|
| The clinical picture of Alzheimer's disease in the decade before diagnosis: clinical and biomarker trajectories. |
|
| Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. |
|
| COSMIC (Cohort Studies of Memory in an International Consortium): an international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups |
|
| Depression in elderly persons subject to childhood maltreatment is not modulated by corpus callosum and hippocampal loss. |
|
| Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. |
|
| Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study |
|
| Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study |
|
| DNA methylation and genetic variation of the angiotensin converting enzyme (ACE) in depression. |
|
| The effect of an adverse psychological environment on salivary cortisol levels in the elderly differs by 5-HTTLPR genotype |
|
| Elderly benzodiazepine users at increased risk of activity limitations: influence of chronicity, indications, and duration of action--the three-city cohort. |
|
| Estrogen and neuropsychiatric disorders in later-life.. |
|
| Estrogen receptor alpha gene variants and major depressive episodes |
|
| Estrogen receptor polymorphisms and incident dementia: the prospective 3C study. |
|
| Estrogènes et pathologies neuropsychiatriques chez les femmes âgées |
|
| Excessive sleepiness is predictive of cognitive decline in the elderly |
|
| The extent to which childhood adversity and recent stress influence all-cause mortality risk in older adults |
|
| Frequent attendance and the concordance between PHQ screening and GP assessment in the detection of common mental disorders |
|
| Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly |
|
| Generalized anxiety disorder in the elderly : role of bio-environmental factors and genetic vulnerability |
|
| Generalized anxiety in community-dwelling elderly: Prevalence and clinical characteristics. |
|
| Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression |
|
| Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age. |
|
| GWAS-identified risk variants for major depressive disorder: Preliminary support for an association with late-life depressive symptoms and brain structural alterations. |
|
| Heterogeneity in HPA axis dysregulation and serotonergic vulnerability to depression. |
|
| Hormonal treatment, mild cognitive impairment and Alzheimer's disease |
|
| Hypnotics and mortality in an elderly general population: a 12-year prospective study. |
|
| Impact of sleep disturbances on kidney function decline in the elderly. |
|
| In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism |
|
| Increased Serum C-reactive Protein and Corpus Callosum Alterations in Older Adults |
|
| Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. |
|
| Investigating the epigenetic profile of the inflammatory gene IL-6 in late-life depression. |
|
| Involvement of GPR50 polymorphisms in depression: independent replication in a prospective elderly cohort |
|
| Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. |
|
| Is Peripheral BDNF Promoter Methylation a Preclinical Biomarker of Dementia? |
|
| Late-life depression and mortality: influence of gender and antidepressant use |
|
| Late-life health consequences of exposure to trauma in a general elderly population: the mediating role of reexperiencing posttraumatic symptoms. |
|
| Late-onset agoraphobia: general population incidence and evidence for a clinical subtype. |
|
| Life-time estrogen exposure and cognitive functioning in later life. |
|
| Lifetime hormonal factors may predict late-life depression in women. |
|
| Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents. |
|
| Lipid lowering agents, cognitive decline, and dementia: the three-city study. |
|
| Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents. |
|
| Metabolic syndrome, its components, and mortality in the elderly |
|
| Modelling complex pathways between late-life depression and disability: evidence for mediating and moderating factors. |
|
| Neurological signs and late-life depressive symptoms in a community population: the ESPRIT study. |
|
| Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study |
|
| Oestradiol level, oestrogen receptors, and mortality in elderly men: The three-city cohort study |
|
| An original method for rapid serial determination of phospholipid biosynthesis. Applications to mammalian lymphocytic cells and a lower eucaryote, Plasmodium falciparum |
|
| Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort. |
|
| Persistence of abnormal cortisol levels in elderly persons after recovery from major depression. |
|
| Phospholipid uptake by Plasmodium knowlesi infected erythrocytes. |
|
| Phospholipides de l'érythrocyte impalude voies métaboliques, régulation, localisation et interférences pharmacologiques |
|
| Polymorphisms of estrogen receptors and risk of depression: therapeutic implications. |
|
| Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder |
|
| Present development concerning antimalarial activity of phospholipid metabolism inhibitors with special reference to in vivo activity. |
|
| Prevalence of DSM-IV psychiatric disorder in the French elderly population. |
|
| The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration. |
|
| Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study |
|
| Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women. |
|
| Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies |
|
| Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (the ESPRIT study) |
|
| Risk profiles for mild cognitive impairment and progression to dementia are gender specific. |
|
| Several lines of evidence demonstrating that Plasmodium falciparum, a parasitic organism, has distinct enzymes for the phosphorylation of choline and ethanolamine |
|
| Sex-specific depressive symptoms as markers of pre-Alzheimer dementia: findings from the Three-City cohort study |
|
| Social activity and improvement in depressive symptoms in older people: a prospective community cohort study. |
|
| Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia. |
|
| Structural brain changes with lifetime trauma and re-experiencing symptoms is 5-HTTLPR genotype-dependent |
|
| Time-dependent cognitive and somatic symptoms of depression as predictors of new cardiac-related events in at-risk patients: the UPBEAT-UK cohort |
|
| Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique |
|
| Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug class. |
|
